Extendicare Stock Market Value

EXETF Stock  USD 16.14  0.06  0.37%   
Extendicare's market value is the price at which a share of Extendicare trades on a public exchange. It measures the collective expectations of Extendicare investors about its performance. Extendicare is trading at 16.14 as of the 15th of January 2026. This is a 0.37 percent increase since the beginning of the trading day. The stock's lowest day price was 16.05.
With this module, you can estimate the performance of a buy and hold strategy of Extendicare and determine expected loss or profit from investing in Extendicare over a given investment horizon. Check out Extendicare Correlation, Extendicare Volatility and Extendicare Alpha and Beta module to complement your research on Extendicare.
Symbol

Please note, there is a significant difference between Extendicare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Extendicare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Extendicare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Extendicare 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Extendicare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Extendicare.
0.00
10/17/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/15/2026
0.00
If you would invest  0.00  in Extendicare on October 17, 2025 and sell it all today you would earn a total of 0.00 from holding Extendicare or generate 0.0% return on investment in Extendicare over 90 days. Extendicare is related to or competes with Rhoen Klinikum, Netcare, RHN KLINIKUM, WashTec AG, Life Healthcare, Panamera Holdings, and Arjo AB. Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada More

Extendicare Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Extendicare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Extendicare upside and downside potential and time the market with a certain degree of confidence.

Extendicare Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Extendicare's standard deviation. In reality, there are many statistical measures that can use Extendicare historical prices to predict the future Extendicare's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Extendicare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.9016.1418.38
Details
Intrinsic
Valuation
LowRealHigh
15.3117.5519.79
Details

Extendicare Backtested Returns

Extendicare appears to be not too volatile, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.32, which denotes the company had a 0.32 % return per unit of risk over the last 3 months. By reviewing Extendicare's technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please utilize Extendicare's Downside Deviation of 1.64, mean deviation of 1.41, and Coefficient Of Variation of 313.63 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Extendicare holds a performance score of 25. The firm shows a Beta (market volatility) of 0.18, which means not very significant fluctuations relative to the market. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's semi variance, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Extendicare's price patterns will revert.

Auto-correlation

    
  -0.04  

Very weak reverse predictability

Extendicare has very weak reverse predictability. Overlapping area represents the amount of predictability between Extendicare time series from 17th of October 2025 to 1st of December 2025 and 1st of December 2025 to 15th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Extendicare price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Extendicare price fluctuation can be explain by its past prices.
Correlation Coefficient-0.04
Spearman Rank Test-0.14
Residual Average0.0
Price Variance0.25

Extendicare lagged returns against current returns

Autocorrelation, which is Extendicare pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Extendicare's pink sheet expected returns. We can calculate the autocorrelation of Extendicare returns to help us make a trade decision. For example, suppose you find that Extendicare has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Extendicare regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Extendicare pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Extendicare pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Extendicare pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Extendicare Lagged Returns

When evaluating Extendicare's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Extendicare pink sheet have on its future price. Extendicare autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Extendicare autocorrelation shows the relationship between Extendicare pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Extendicare.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Extendicare Pink Sheet

Extendicare financial ratios help investors to determine whether Extendicare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.